Closing of the divestiture of CRYOPDP to Hivest Capital Partners

Paris, France, July 30, 2020

In accordance with the agreement initially announced on March 2, 2020, Air Liquide has now closed the sale of its subsidiary CRYOPDP to  French private equity firm Hivest Capital Partners.

This decision illustrates Air Liquide’s strategy to regularly review its asset portfolio in order to focus on key businesses and geographies so as to maximize its performances. 

One of the top leaders in its field, CRYOPDP aims to improve the health of people around the world by providing global innovative temperature-controlled logistics solutions to the Clinical Research and Cell & Gene Therapy Communities. With headquarters in France, CRYOPDP has more than 250 employees in 12 countries and operates in more than 150 countries.